New diabetes clinical trial: Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Published on: September 21, 2023 at 11:00AM
Conditions: Cardiovascular Diseases; Diabetes
Interventions: Drug: SGLT2 inhibitor, GLP-1 RA; Behavioral: Education-First
Sponsors: Brigham and Women's Hospital; Novo Nordisk A/S via Research Grant to Brigham and Women's Hospital
Completed
https://ift.tt/3HLGasq
Conditions: Cardiovascular Diseases; Diabetes
Interventions: Drug: SGLT2 inhibitor, GLP-1 RA; Behavioral: Education-First
Sponsors: Brigham and Women's Hospital; Novo Nordisk A/S via Research Grant to Brigham and Women's Hospital
Completed
https://ift.tt/3HLGasq
Comments
Post a Comment